Glycoprotein Ib (GPlbl. the receptor for von Willebrand factor, is a two-chain member constituent of the platelet/ megakaryocytic lineage. Studies on its expression have been hampered by the difficulties in obtaining purified megakaryocytes in a sufficient number. We report a suspension liquid culture procedure that allowed isolation of more than 1 x lo'megakaryocytes with a purity ranging from 3% to 88% from the blood of patients with chronic myeloid leukemia, from fetal liver or from normal human bone marrow. GPlb was detected on the plasma membrane of all maturing megakaryocytes and also of promegakaryoblasts devoid of demarcation membranes. GPlb was detected on demarcation membranes of maturing mega-LOOD PLATELET adhesion to exposed vascular suben-B dothelium requires a plasma component, von Willebrand factor (vWF), and its specific platelet receptor, glycoprotein Ib (GPIb).'.' GPIb has an apparent molecular weight (mol wf) of 170 Kd and consists of two disulfide-linked subunits, GPIb CY (mol wt, 143 Kd) and GPIb , f 3 (mol wt, 22 Kd),3 which are complexed in a 1:l ratio with another membrane glycoprotein, GPIX (mol wt, 17 Kd).4*5
karyocytes but was absent from all other organelles, including cy granules. Biosynthesis of 36S-methionine labeled megakaryocytes showed that GPlb with similar electrophoretic mobility to the platelet molecule was synthesized and that it was also composed of two chains, since its molecular weight shifted in reducing conditions from 170 Kd to 145 Kd. The @ chain remained undetectable after methionine metabolic labeling, but it was immunoprecipitated after 3H-leucine metabolic labeling, confirming that this subunit is devoid of methionine. GPlb was associated with GPIX, as it is in platelets, since anti-GPlb antibodies coprecipitated a 17 Kd polypeptide. 0 1990 by The American Society of Hematology.
obtained from patients with CML after informed consent before chemotherapy. Fetal livers were resected from 9-to 20-week-old fetuses that had been aborted for nonhematologic reasons. All these samples were obtained in accordance with institutional guidelines of the Committee on Human Investigation. Single cell suspensions were made from fetal livers by gentle manipulation to produce small fragments and passing them through fine meshes. Low-density cells were separated by velocity centrifugation on Ficoll-metrizoate (d = 1.077) (Seromed, Berlin, FRG).
Low-density blood cells from CML patients were cultured in suspension in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% plasma from patients with aplastic marrows (patients having undergone a bone marrow transplantation), whereas cells from fetal liver or normal bone marrow were cultured in IMDM containing 10% plasma from patients with aplastic marrows, 1% bovine serum albumin, and 2.5% phytohemagglutinin leucocyte-conditioned medium (PHA-LCM)." Cell cultures were done for 10 to 14 days in 25 cm2 or 75 cm2 tissue culture flasks (Corning Glasswork Co, Corning, NY) at 37OC in a 5% CO, fully humidified atmosphere.
Cultured cells were harvested and washed twice in CATCH medium'* or in phosphate-buffered saline (PBS) containing 1 mmol/L adenosine (Sigma, St Louis, MO) and 2 mmol/L theophylline (Sigma, St Louis, MO). The two media were supplemented with 100 U/mL DNase1 (Boehringer Mannheim GmbH, Mannheim, FRG) and 4% fetal calf serum (Boehringer Mannheim GmbH).
Indirect immunofluorescent labeling was carried out as previously described." For cell surface antigens, monoclonal antibodies directed against GPIb (ANSl"), GPIIb (TabI4), GPIIIa (C17I5), and GPIX (FMC 2516) were used on unfixed cells, and antibody binding was revealed by sheep anti-mouse F(ab'), fragments conjugated with fluorescein isothiocyanate (Bioart, Meudon, France). For intracellular labeling, a single monoclonal antibody or a pool of various monoclonal antibodies against GPIb 01 (AN 51, AP l,I7 S Z 2," and WM 2319), as well as polyclonal rabbit anti-glycocalicin IgGzo and a rabbit antiserum against vWF (Dakopatts, Clostrup, Denmark) were used. Intracellular labeling was done by applying the antibodies to cytocentrifuged preparations of cultured cells which had been fixed for 1 minute by pure methanol. Cells were observed with a Zeiss fluorescent microscope.
Unfixed cells obtained at day 7 of culture (lo7) were incubated for 2 hours at 4OC with rabbit anti-glycocalicin antibody at 1/50 dilution. After two washes in Hanks medium at 4OC, cells were incubated at 4°C with 200 pL of purified IgG from goat anti-rabbit IgG serum coupled to 5
Cell culture.
Indirect immunojuorescence.
Ultrastructural and immunogold staining. nm gold particles (Janssen Pharmaceutica, Beerse, Belgium) and washed twice. They were then fixed by 1.25% glutaraldehyde in Gey's buffer2' for 10 minutes, washed, and incubated in diaminobenzidine medium.22 Cells were then post-fixed with osmium tetroxide, dehydrated, and embedded in epon. Thin sections were examined with a Philips CM 10 electron microscope after lead citrate staining. Double labeling was done on MK obtained at day 10 of culture, using a mixture of anti-glycocalicin in antibody at the same dilution as above and C 17 antibody diluted 100 times in Hanks medium. A 1-hour incubation was done at 4OC. After two washes in cold buffer, a mixture of purified IgG from goat anti-rabbit IgG serum coupled to 5 nm gold particles and purified IgG from goat anti-mouse IgG serum coupled to 15 nm gold particles (Janssen Pharmaceutica, Beerse, Belgium) was added for 1 hour at 4OC; the pellet was subsequently treated as above.
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For ultrastructural intracellular labeling, cells cultured for 10 days were fixed in 1% glutaraldehyde in 0.1 mol/L phosphate buffer pH 7.2 for 1 hour at rmm temperature, washed three times in the same buffer and embedded in glycol-methacrylate. 23 Thin sections were collected on nickel grids coated with formavar, and a rabbit anti-glycocalicin serum was applied at a 1/50 dilution for 2 hours, followed by goat IgG directed against rabbit IgG coupled to 5 nm colloidal particles (GARG 5, Janssen Pharmaceutica), diluted 10 times for 2 hours at 4 O C Z 4 Normal rabbit serum was used in place of the primary antiserum as a negative control.
Cultured cells were washed once in Dulbecco's medium (Boehringer Mannheim) and resuspended at 1 x lo6 cells/mL in methionine-free medium supplemented with 10% heat-inactivated dialyzed fetal calf serum.
After 10 minutes at 37OC, 50 pCi/mL of "S-methionine (AmerMetabolic radiolabeling of cultured MK. sham, Buckinghamshire, UK; specific activity, greater than 800 Ci/mmol) was added, and the cells were cultured in a Petri dish for up to 48 hours at 37°C in a 5% CO, fully humidified atmosphere. In other experiments, metabolic labeling was done similarly with 1OC pCi/mL 'H leucine (Commissariat B I'tnergie atomique, Gif-sur Yvette, France; specific activity, 150 Ci/mmol) in leucine-free medium.
Immunoprecipitation and sodium dodecyl sulfote-polyacrylamide gel electrophoresis. Immunoprecipitation experiments were done as previously described.6 Briefly, radiolabeled cells were washed twice in Dulbecco's medium, then lysed in lysis buffer, pH 7.4 (Tris 10 mmol/L, NaCl 150 mmol/L, Triton X-100 1%, phenylmethylsufonyl flouride [PMSF] 2 mmol/L). Triton X-100-insoluble material was removed by centrifuging the samples of 100,OOOg for 30 minutes at 4OC. Samples (2 x IO6 cultured cells) were incubated at 4OC with 5 pL of either a pool of monoclonal antibodies against the GPIb a chain (AN 51, AP 1, WM 23) or C 17 monoclonal antibody (anti-GPIIIa). After an incubation of 3 hours, 25 pL of protein A-Sepharose CL-4B was added, and the incubation was continued for 1 hour at 4OC. Protein A-Sepharose beads were washed six times with lysis buffer, and the final pellet was resuspended in 50 pL of IO mmol/L Tris-HCI, pH 7.4, containing 2% (wt/vol) sodium dodecyl sulfate (SDS) and 5% 2-mercaptoethanol. Bound proteins were shows a small PMKB with an irregular nucleus. The square indicates the part of the cell that is enlarged. A t higher magnification (original magnification, x32,OOO). the cytoplasmic membrane exhibits a double labeling for GPllla sites (large arrows) and for glycocalicin Ismall arrows). Note that the cytoplasm predominantly contains ribosomes. (B) This larger cell has its cytoplasmic membrane more strongly labeled for glycocalicin (small arrows) than for GPllla (large arrows). The cytoplasm does not show any smooth membranes that would correspond t o DM, but numerous polyribosomes and cisternae of rough endoplasmic reticulum IRER) are present. Original magnification, ~25,000.
eluted by heating the suspension at 100°C for 5 minutes and analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) on 7% to 12% or 7% to 15% polyacrylamide gradient slab gels according to the method of Laemmli." After electrophoresis, the gels were fixed, processed for fluorography with Amplify (Amersham), dried, and exposed for autoradiography at -8OOC to Kodak XAR-5 films (Kodak-Patht, Marne-la vallte, France).
RESULTS
Cultures were first done as previously reported by Duperray et aIz6 and Berthier et aI2' using blood cells from C M L patients, with the exception that plasma from patients with aplastic marrows was used. MK (cells labeled with anti-GPlb or anti-vWF or anti-GPllb or Illa antibodies) were obtained with a purity of 50% and 88% from two C M L patients but with much less purity in the others (Table 1 ). Contaminant cells were mostly macrophage, neutrophil, and eosinophil precursors. However, we were unable to obtain MK at a proportion exceeding 10% from fetal liver or marrow cells using these culture conditions. Therefore, we cultured these samples in the presence of PHA-LCM. However, PHA-LCM also stimulated colonyforming units-granulocyte/macrophage (CFU-GM) differentiation and eliminated myeloid precursors, which become transiently adherent during differentiation, by transferring culture supernatants each day into a new culture flask starting from day 6. These cultured MK were derived from the CFU-MK differentiation. Indeed, the percentage of MKs was less than 0.3% until day 6, when their number increased greatly until day 9 or IO. These results paralleled those previously obtained in plasma clot cultures. 28 An average of 48% MK (from 30% to 60%) was obtained from six different fetal livers (range, 9-to 20-week-old) ( Table 2) . Results were less reproducible from bone marrow ranging from 3% to 50% (10 samples) ( Table 3) . due partly to the difficulty of eliminating adherent cells. Total MK recovery was much lower than from fetal liver cells. Contaminant cells were macrophages and myeloid precursors essentially of the eosinophil series.
MK from either C M L blood or marrow or fetal liver cultures displayed a typical membrane labeling for GPlb: In double-staining experiments, all MK (identified by their expression of vWF) bore GPlb, and similar results were obtained for GPIX. The cytoplasmic localization of GPlb was first determined by immunofluorescence. At day 7, when most MK were still immature, GPlb was localized in the cytoplasm, usually either in small foci close to the cytoplasmic membrane (Fig  la) or as bigger patches within the cytoplasm (Fig Ib) . Labeling became more intense during culture, first scattered in the cytoplasm and then more diffusively distributed ( Fig  IC) . Other cell types were GPlb negative. Similar results were obtained with single monoclonal antibodies, with a pool of monoclonal antibodies, and with a polyclonal antibody.
Ultrastructural immunostaining on living cells (see Materials and Methods) showed that a small percentage of small promegakaryoblasts (PMKB) expressed only GPIIla, while the majority of them were labeled both for GPIb and GPIIIa (Fig 2A) . confirming that G P llla is present on the membrane earlier than GPIb.ln In larger immature MKs, more intense labeling for GPlb was seen even before the appearance of DM (Fig 2B) . When few immature a-granules appeared in large megakaryoblasts, DM were still absent despite a strong GPIb expression (Fig 3) . Cell membrane labeling was discontinuous, all cytoplasmic expansions (blebs) being negative (Fig 4) . whereas pseudopods were stained (Fig 3) .This was also true for GPIIIa (data not shown). A minor proportion of the antibody was pinocytosed in the cytoplasm. Controls (preimmune rabbit serum or a rabbit anti-serum against glycophorin A) did not give any membrane labeling.
On more mature megakaryoblasts exhibiting a multilobulated nucleus and nucleolus, DM at the periphery of the cell were labeled by both antibodies. However, 5 nm gold particles (GPlb) were more numerous than 15 nm particles (GPIIIa). In order to decide whether this was an artifact due to the limited penetration of the larger particles, cells were labeled using anti-GPIb and anti-GPIIIa antibodies with identical size gold particles (ie, 5 nm), and. under these conditions, DM were labeled with the same intensity by each reagent.
When MK embedded in glycol-methacrylate were labeled by the anti-glycocalicin antibody, all DM were intensely labeled for GPlb (Fig 5A, B, and C) , whereas no labeling was observed in a-granules or mitochondria, suggesting that the restricted labeling of DM in living cells is due to the limited penetration of antibody. Discrete labeling was associated with the membrane of some Golgi saccules and in a few 
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blood, fetal liver, or bone marrow, as well as high molecular weight material that penetrated the gel poorly (Fig 6) . Under reducing conditions the 160 Kd band shifted to an apparent mol wt of 135 Kd (GPlb a). No low molecular weight band corresponding to GPIb @ chain (mol wt 22 Kd) could be seen. The high molecular weight material resolved into a major band of mol wt 220 Kd (actin binding protein) and three minor bands of mol wts of 92 Kd, 44 Kd, and 30 Kd previously shown to coprecipitate with GPIb, which could correspond to membrane skeleton proteins.' These latter proteins were not precipitated with a monoclonal antiGPIIIa, which precipitated two major polypeptides migrating under nonreducing conditions with an apparent mol wt of 130 Kd (GPIIb) and 90 Kd (GPIIIa) and as three bands of mol wt 120 Kd, 100 Kd, and 25 Kd corresponding to GPIIb a, GPIIIa, and GPIIb 8, respectively, under reducing conditions.
In similar experiments done after 24 hours of metabolic labeling with 'H leucine, the monoclonal antibodies against GPIb precipitated three major bands of mol wt 130 Kd, 22 Kd, and 17 Kd corresponding to GPIb a, GPIb @, and GPIX, respectively, under reducing conditions and two main bands (160 Kd, GPIb and 17 Kd, GPIX) under nonreducing conditions (Fig 7) .
DISCUSSION
In this report, we have shown that a simple cell culture technique in liquid medium allows sufficient numbers of MK to be recovered for ultrastructural immunocytochemistry and biochemical studies from either blood cells of CML patients or from normal fetal liver or adult bone marrow. This culture technique is based only on the use of adequate stimulators (ie, plasma from patients with aplastic marrows, PHA-LCM), high cell concentration, and the continuous elimination of the adherent non-megakaryocytic cells throughout the culture procedure. In contrast to results from fetal liver, results from normal marrow were variable, depending upon the sample. However, for more than half the marrow specimens, sufficiently pure (20% to 50%) and numerous MK were obtained to allow precise studies of their GPIb expression, since this molecule was not detected by immunolabeling and biosynthesis in the contaminant cell population.
All identifiable cultured MK expressed both GPIb and GPIIIa. This is in contradiction with a recent report that only an average of 24% of mature MK isolated from bone marrow express GPIb.29 This discrepancy may be related to the rapid cleavage of glycocalicin from GPIb by calcium-dependent protease^'.'^ during their isolation, since we also found that all marrow MK express GPIb (data not shown). In addition, our results confirm that GPIb is expressed on the plasma membrane of some immature megakaryocytic cells. Before the production of DM,*' GPIb was detected on the entire DM system, suggesting that there is no difference between the plasma membrane and DM for this determinant. Some DM in unfixed MK remained unlabeled by anti-GPIb or antiGPIIIa antibodies, but this appeared to be due to a poor penetration of the DM system by the antibodies, since DM were less intensely labeled by antibodies coupled to 15 nm gold particles than by those coupled to smaller gold particles. Furthermore, staining reaction was done by 4OC, since at 37OC, even in the presence of sodium azide, we could not inhibit an intense pinocytosis of the antibody, which rendered the ultrastructural localization of the immunolabeling difficult. Previous studies using dense tracers as a probe have shown that a temperature of 37OC was necessary to penetrate the lumen of all DM.3' In addition, it may be noted that only GPlb a from 3H-leucine metabolically labeled MK. Experiment was done as above with the exception that cultured cells were labeled with 3H-leucine for 24 hours. Triton X-100 cell extracts were immunoprecipitated by the same pool of monoclonal antibodies directed against GPlb a, and the precipitates were resolved by 7% to 12% gradient SDS-PAGE in the presence (R) or the absence (NR) of 5% 2-mercapthoethanol. Lane A, 14C-methylated standard molecular weight markers (from top to bottom: myosin, mol wt 200.000: phosphorylase b, mol wt 92,500; bovine serum albumin, mol wt 69,000; ovalbumin, mol wt 46,000: carbonic anhydrase, mol wt 30,000; lysosyme, mol wt the DM located far from the periphery in large mature M K remained unlabeled whereas similar DM in smaller M K were stained. Finally, we have shown previously that aldehyde fixation prevents antibodies from penetrating the lumen of DM.32 Therefore, it can be assumed that all DM communicate with the outside,33 but that under certain technical conditions, this system may be inaccessible to an antibody.
GPIb could be found only on the D M system and was undetectable in other MK organelles, especially a-granules. Recent biochemical studies have shown a large intracytoplasmic pool of GPIb in platelet^,'^ and GPIb has been detected by ultrastructural immunolabeling on intracellular membrane-bound vacuolar structures. However, this membrane system could not be identified and the present work suggests that the intracellular pool of GPIb in platelets is located on the open canalicular system.
The biosynthetic results provide evidence that cultured MK, in contrast to HEL cells, synthesize a GPIb identical in size to platelet GPIb. As in platelets, GPIb forms a complex with GPIX in MK and is associated with elements of the membrane ~k e l e t o n $~. *~*~~ since anti-GPIb CY monoclonal antibodies coprecipitated GPIX and several proteins of the membrane skeleton previously characterized by Wicki and Clemetson.' Due to the absence of methionine residues in the GPIb /3 hai in,^' no band corresponding to GPIb /3 was visualized. However, the shift in the apparent molecular weight of GPIb after disulfide cleavage provides clear evidence that the GPIb /3 chain is synthesized and associated with GPIb a. This result was further confirmed after leucine metabolic labeling, which allowed immunoprecipitated GPIb /3 chain to be visualized.
Further investigations are needed to investigate the entire processing of GPIb in MK.
